88 related articles for article (PubMed ID: 32820924)
1. Computational and Experimental Characterization of NF023, A Candidate Anticancer Compound Inhibiting cIAP2/TRAF2 Assembly.
Cossu F; Sorrentino L; Fagnani E; Zaffaroni M; Milani M; Giorgino T; Mastrangelo E
J Chem Inf Model; 2020 Oct; 60(10):5036-5044. PubMed ID: 32820924
[TBL] [Abstract][Full Text] [Related]
2. NF023 binding to XIAP-BIR1: searching drugs for regulation of the NF-κB pathway.
Cossu F; Milani M; Grassi S; Malvezzi F; Corti A; Bolognesi M; Mastrangelo E
Proteins; 2015 Apr; 83(4):612-20. PubMed ID: 25619915
[TBL] [Abstract][Full Text] [Related]
3. TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB.
Garrison JB; Samuel T; Reed JC
Oncogene; 2009 Apr; 28(13):1584-93. PubMed ID: 19234489
[TBL] [Abstract][Full Text] [Related]
4. Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK.
Zarnegar BJ; Wang Y; Mahoney DJ; Dempsey PW; Cheung HH; He J; Shiba T; Yang X; Yeh WC; Mak TW; Korneluk RG; Cheng G
Nat Immunol; 2008 Dec; 9(12):1371-8. PubMed ID: 18997794
[TBL] [Abstract][Full Text] [Related]
5. Crystal structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 complexes: affinity, specificity, and regulation.
Zheng C; Kabaleeswaran V; Wang Y; Cheng G; Wu H
Mol Cell; 2010 Apr; 38(1):101-13. PubMed ID: 20385093
[TBL] [Abstract][Full Text] [Related]
6. Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases.
Samuel T; Welsh K; Lober T; Togo SH; Zapata JM; Reed JC
J Biol Chem; 2006 Jan; 281(2):1080-90. PubMed ID: 16282325
[TBL] [Abstract][Full Text] [Related]
7. Birinapant (TL32711), a bivalent SMAC mimetic, targets TRAF2-associated cIAPs, abrogates TNF-induced NF-κB activation, and is active in patient-derived xenograft models.
Benetatos CA; Mitsuuchi Y; Burns JM; Neiman EM; Condon SM; Yu G; Seipel ME; Kapoor GS; Laporte MG; Rippin SR; Deng Y; Hendi MS; Tirunahari PK; Lee YH; Haimowitz T; Alexander MD; Graham MA; Weng D; Shi Y; McKinlay MA; Chunduru SK
Mol Cancer Ther; 2014 Apr; 13(4):867-79. PubMed ID: 24563541
[TBL] [Abstract][Full Text] [Related]
8. The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2.
Varfolomeev E; Wayson SM; Dixit VM; Fairbrother WJ; Vucic D
J Biol Chem; 2006 Sep; 281(39):29022-9. PubMed ID: 16891304
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric recruitment of cIAPs by TRAF2.
Mace PD; Smits C; Vaux DL; Silke J; Day CL
J Mol Biol; 2010 Jul; 400(1):8-15. PubMed ID: 20447407
[TBL] [Abstract][Full Text] [Related]
10. NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2.
Diessenbacher P; Hupe M; Sprick MR; Kerstan A; Geserick P; Haas TL; Wachter T; Neumann M; Walczak H; Silke J; Leverkus M
J Invest Dermatol; 2008 May; 128(5):1134-47. PubMed ID: 17989734
[TBL] [Abstract][Full Text] [Related]
11. A dual role for the API2 moiety in API2-MALT1-dependent NF-kappaB activation: heterotypic oligomerization and TRAF2 recruitment.
Lucas PC; Kuffa P; Gu S; Kohrt D; Kim DS; Siu K; Jin X; Swenson J; McAllister-Lucas LM
Oncogene; 2007 Aug; 26(38):5643-54. PubMed ID: 17334391
[TBL] [Abstract][Full Text] [Related]
12. Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response.
Gardam S; Turner VM; Anderton H; Limaye S; Basten A; Koentgen F; Vaux DL; Silke J; Brink R
Blood; 2011 Apr; 117(15):4041-51. PubMed ID: 21300983
[TBL] [Abstract][Full Text] [Related]
13. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling.
Vallabhapurapu S; Matsuzawa A; Zhang W; Tseng PH; Keats JJ; Wang H; Vignali DA; Bergsagel PL; Karin M
Nat Immunol; 2008 Dec; 9(12):1364-70. PubMed ID: 18997792
[TBL] [Abstract][Full Text] [Related]
14. Structure-Activity Relationship of NF023 Derivatives Binding to XIAP-BIR1.
Sorrentino L; Cossu F; Milani M; Malkoc B; Huang WC; Tsay SC; Ru Hwu J; Mastrangelo E
ChemistryOpen; 2019 Apr; 8(4):476-482. PubMed ID: 31011505
[TBL] [Abstract][Full Text] [Related]
15. TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-kappaB signaling.
Kanno Y; Sakurai D; Hase H; Kojima H; Kobata T
J Recept Signal Transduct Res; 2010 Apr; 30(2):121-32. PubMed ID: 20184394
[TBL] [Abstract][Full Text] [Related]
16. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor (TNF) receptor-associated factor (TRAF)-interacting protein (TRIP) negatively regulates the TRAF2 ubiquitin-dependent pathway by suppressing the TRAF2-sphingosine 1-phosphate (S1P) interaction.
Park ES; Choi S; Shin B; Yu J; Yu J; Hwang JM; Yun H; Chung YH; Choi JS; Choi Y; Rho J
J Biol Chem; 2015 Apr; 290(15):9660-73. PubMed ID: 25716317
[TBL] [Abstract][Full Text] [Related]
18. Cellular inhibitors of apoptosis are global regulators of NF-κB and MAPK activation by members of the TNF family of receptors.
Varfolomeev E; Goncharov T; Maecker H; Zobel K; Kömüves LG; Deshayes K; Vucic D
Sci Signal; 2012 Mar; 5(216):ra22. PubMed ID: 22434933
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor receptor-associated factor (TRAF) 1 regulates CD40-induced TRAF2-mediated NF-kappaB activation.
Fotin-Mleczek M; Henkler F; Hausser A; Glauner H; Samel D; Graness A; Scheurich P; Mauri D; Wajant H
J Biol Chem; 2004 Jan; 279(1):677-85. PubMed ID: 14557256
[TBL] [Abstract][Full Text] [Related]
20. IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis.
Gyrd-Hansen M; Darding M; Miasari M; Santoro MM; Zender L; Xue W; Tenev T; da Fonseca PC; Zvelebil M; Bujnicki JM; Lowe S; Silke J; Meier P
Nat Cell Biol; 2008 Nov; 10(11):1309-17. PubMed ID: 18931663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
